banner
IL receptor inhibitor MCC950 sodium, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ585

IL receptor inhibitor MCC950 sodium, Purity ≥98%

Synonym: MCC950 sodium; 256373-96-3; CRID3 sodium salt; CP-456773 sodium; MCC950 sodium salt; MCC950 (sodium); IL receptor inhibitor

  • MDL: MFCD30478884
  • CAS Number: 256373-96-3
  • Compound CID: 91826093
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MCC950 sodium, soluble in water and ethanol and insoluble in DMSO, blocks the binding of interleukins (cytokines) to their corresponding receptors on the cell surface, thereby inhibiting the downstream signaling pathways. It targets NLRP3.
Molecular Weight
426.46
Molecular Formula
C20H23N2NaO5S
Targets
NLRP3: 7.5 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: Insoluble; Water: 77 mg/mL (180.55 mM); Ethanol: 36 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
MCC950 sodium can be used to investigate its selective inhibition of the NLRP3 inflammasome in inflammation and autoimmune diseases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0